Concurrent hyperfractionated radiation therapy and chemotherapy in locally advanced (Stage III) non-small-cell lung cancer: Single institution experience with 600 patients

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 3, 2012, Pages 1157-1163

  Jeremić, Branislav ^a   Miličić, Biljana ^a   Milisavljevic, Slobodan ^a  

^a University Hospital   (Serbia)

Author keywords

Chemotherapy; Locally advanced non small cell lung cancer; Radiation therapy

Indexed keywords

CARBOPLATIN; ESOPHAGITIS; ETOPOSIDE; LOCALLY ADVANCED NON-SMALL-CELL LUNG CANCER; LOW TOXICITY; MEDIAN SURVIVAL TIME; NON SMALL CELL LUNG CANCER; PACLITAXEL; PHASE II; PROGRESSION FREE SURVIVAL; THREE PHASE; TWO PHASE;

BIOLOGICAL ORGANS; CELLS; CHEMOTHERAPY; DISEASES; TOXICITY;

RADIOTHERAPY;

CARBOPLATIN; ETOPOSIDE; PACLITAXEL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLOOD TOXICITY; BRONCHOPULMONARY TOXICITY; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER STAGING; CONTROLLED STUDY; DISTANT METASTASIS FREE SURVIVAL; DOSIMETRY; DRUG DOSE TITRATION; ESOPHAGITIS; ESOPHAGUS TOXICITY; FEMALE; HUMAN; LOCAL PROGRESSION FREE SURVIVAL; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PNEUMONIA; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RADIATION PNEUMONIA; RANDOMIZED CONTROLLED TRIAL; SURVIVAL TIME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; DRUG ADMINISTRATION SCHEDULE; ESOPHAGITIS; ETOPOSIDE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PACLITAXEL; PNEUMONIA; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84856365379     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.04.016     Document Type: Article

References (34)

1. R.O. Dillman, J. Herndon, and S.L. Seagren Improved survival in Stage III non-small-cell lung cancer: Seven-year follow-up of Cancer and Leukemia Group B (CALGB) 8433 trial J Natl Cancer Inst 88 1996 1210 1215
2. T. LeChevalier, R. Arriagada, and M.-J. Lacombe-Terrier Significant effect of adjuvant chemotherapy on survival in locally advanced non-small cell lung carcinoma J Natl Cancer Inst 84 1992 58
3. W.T. Sause, P. Kolesar, and S. Taylor IV Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer. Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group Chest 117 2000 358 364
4. M.G. Trovo, E. Minatel, and A. Veronesi Combined radiotherapy and chemotherapy versus radiotherapy alone in locally advanced epidermoid bronchogenic carcinoma. A randomized study Cancer 65 1990 400 404
5. R.F. Morton, J.R. Jett, and W.L. McGinnis Thoracic radiation therapy alone compared with combined chemoradiotherapy for locally unresectable non-small cell lung cancer. A randomized, phase III trial Ann Int Med 115 1991 681 686
6. M.G. Trovo, E. Minatel, and G. Franchin Radiotherapy versus radiotherapy enhanced by cisplatin in stage III non-small cell lung cancer Int J Radiat Oncol Biol Phys 24 1992 11 15
7. C. Blanke, R. Ansari, and R. Mantravadi Phase III trial of thoracic irradiation with or without cisplatin for locally advanced unresectable non-small-cell lung cancer: A Hoosier Oncology Group protocol J Clin Oncol 13 1995 1425 1429
8. C. Schaake-Konig, W. van der Bogaert, and O. Dalesio Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer N Engl J Med 326 1992 524 530
9. A. Auperin, C. Le Pechoux, and J.P. Pignon Concomitant radiochemotherapy based on platin compounds in patients with locally advanced non-small cell lung cancer (NSCLC): A meta-analysis of individual data from 1,764 patients Ann Oncol 17 2006 473 483
10. A. Aupérin, C. Le Péchoux, and E. Rolland Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer J Clin Oncol 28 2010 2181 2190
11. H.-Y. Liang, H. Zhou, and H.-L. Li Chemo-radiotherapy for advanced non-small cell lung cancer: concurrent or sequential? It's no longer the question: A systematic review Int J Cancer 127 2010 718 728
12. W.J. Curran Jr., C. Scott, and C. Langer Phase III comparison of sequential Vs concurrent chemoradiation for pts with unresected stage III non-small cell lung cancer (NSCLC): Initial report of Radiation Therapy Oncology Group (RTOG) 9410 Proc Am Soc Clin Oncol 19 2000 484a
13. K. Furuse, H. Nishikawa, and Y. Takada Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine and cisplatin in unresectable stage III non-small-cell lung cancer J Clin Oncol 17 1999 2692 2699
14. B. Jeremic, Y. Shibamoto, and Lj Acimovic Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III non-small-cell lung cancer J Clin Oncol 13 1995 452 458
15. B. Jeremic, Y. Shibamoto, and Lj Acimovic Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for stage III non-small-cell lung cancer: A randomized study J Clin Oncol 14 1996 1065 1070
16. B. Jeremic, Y. Shibamoto, and B. Milicic Concurrent radiochemotherapy for patients with stage III non-small cell lung cancer (NSCLC). Long-term results of a phase II study Int J Radiat Oncol Biol Phys 42 1998 1091 1096
17. B. Jeremic, Y. Shibamoto, and L.J. Acimovic Hyperfractionated radiation therapy and concurrent low-dose, daily carboplatin/etoposide with or without week-end carboplatin/etoposide chemotherapy in stage III non-small-cell lung cancer: A randomized trial Int J Radiat Oncol Biol Phys 50 2001 19 25
18. B. Jeremic, B. Milicic, and L. Acimovic Concurrent hyperfractionated radiotherapy and low-dose daily carboplatin/paclitaxel in patients with stage III non-small cell lung cancer (NSCLC). Long-term results of a phase II study J Clin Oncol 23 2005 1144 1151
19. C.F. Mountain A new international staging system for lung cancer Chest 89 1986 225S 233S
20. J.D. Cox, J. Stetz, and T.F. Pajak Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for the Treatment and Research of Cancer (EORTC) Int J Radiat Oncol Biol Phys 31 1995 1341 1346
21. J.D. Cox, N. Azarnia, and R.W. Byhardt A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: Possible survival benefit with >69.6 Gy in favorable patients with Radiation Therapy Oncology Group Stage III non-small cell lung carcinoma: Report of Radiation Therapy Oncology Group 83-11 J Clin Oncol 8 1990 1543 1555
22. G. Clamon, J. Herndon, and R. Cooper Radiosensitization with carboplatin for patients with unresectable stage III non-small-cell lung cancer: A phase III trial of the cancer and Leukemia group B and the Eastern Cooperative Oncology Group J Clin Oncol 17 1999 4 11
23. M.A. Socinski, A.W. Blackstock, and J.A. Bogart Randomized phase II trial of induction chemotherapy followed by concurrent chemotherapy and dose-escalated thoracic conformal radiotherapy (74 Gy) in stage III non-small-cell lung cancer: CALGB 30105 J Clin Oncol 26 2008 2457 2463
24. E.E. Vokes, J.E. Herndon 2nd, and M.J. Kelley Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III Non-small-cell lung cancer: Cancer and Leukemia Group B J Clin Oncol 25 2007 1698 1704
25. C.P. Belani, W. Wang, and D.H. Johnson Phase III study of the Eastern Cooperative Oncology Group (ECOG 2597): Induction chemotherapy followed by either standard thoracic radiotherapy or hyperfractionated accelerated radiotherapy for patients with unresectable stage IIIA and B non-small-cell lung cancer J Clin Oncol 23 2005 3760 3767
26. S.Y. El Sharouni, H.B. Kal, and J.J. Battermann Accelerated regrowth of non-small-cell lung tumours after induction chemotherapy Br J Cancer 89 2003 2184 2189
27. N. Hanna, M. Neubauer, and C. Yiannoutsos Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small-cell lung cancer: The Hoosier Oncology Group and U.S. Oncology J Clin Oncol 26 2008 5755 5760
28. K.S. Albain, J.J. Crowley, and A.T. Turrisi III Concurrent cisplatin, etoposide, and chest radiotherapy in pathologic stage IIIB non-small-cell lung cancer: A Southwest Oncology Group phase II study, SWOG 9019 J Clin Oncol 20 2002 3454 3460
29. D.R. Gandara, K. Chansky, and K.S. Albain Consolidation docetaxel after concurrent chemoradiotherapy in stage IIIB non-small-cell lung cancer: Phase II Southwest Oncology Group Study S9504 J Clin Oncol 21 2003 2004 2010
30. C.P. Belani, H. Choy, and P. Bonomi Combined chemoradiotherapy regimens of paclitaxel and carboplatin for locally advanced non-small-cell lung cancer: A randomized phase II locally advanced multimodality protocol J Clin Oncol 23 2005 5883 5891
31. K. Kelly, K. Chansky, and L.E. Gaspar Phase III trial of maintenance gefitinib or placebo after concurrent chemoradiotherapy and docetaxel consolidation in inoperable stage III non-small-cell lung cancer: SWOG S0023 J Clin Oncol 26 2008 2450 2456
32. J.S. Lee, C. Scott, and R. Komaki Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable non-small-cell lung cancer: Radiation Therapy Oncology Group protocol 91-06 J Clin Oncol 14 1996 1055 1064
33. R. Komaki, C. Scott, and D. Ettinger Randomized study of chemotherapy/radiation therapy combinations for favorable patients with locally advanced inoperable nonsmall cell lung cancer: Radiation Therapy Oncology Group (RTOG) 92-04 Int J Radiat Oncol Biol Phys 38 1997 149 155
34. R.W. Byhardt, C.B. Scott, and D.S. Ettinger Concurrent hyperfractionated irradiation and chemotherapy for unresectable nonsmall cell lung cancer. Results of Radiation Therapy Oncology Group 90-15 Cancer 75 1995 2337 2344